MORRIS PLAINS, N.J., March 15, 2010 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that Cynthia L. Sullivan, President and Chief Executive Officer, will be presenting at the Barclays Capital 2010 Global Healthcare Conference, scheduled for March 23-24, 2010 at the Loews Miami Hotel, Florida. The presentation, which is scheduled for Wednesday, March 24 at 3:15 p.m. (ET), can be accessed at www.immunomedics.com/1aboutus/present.pdf, and will provide a corporate overview, including comments on the Company's product portfolio.
